ESCMID eLibrary

Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

11. M030

    When to start treatment: VAT (ventilator-associated tracheo-bronchitis) or VAP (pneumonia)?

    Garyfallia Poulakou, Athens, Greece

    25 April 2015

    Session: When to start treatment: VAT (ventilator-associated tracheo-bronchitis) or VAP (pneumonia)?

    Relevance:

     

    100%

     

    

    Event: ECCMID 2015
    Copenhagen, Denmark
    Meet-the-Expert lecture

    Healthcare-associated & Nosocomial Infections, Infection Control

12. P0260

    Definition and significance of salvage treatment for Gram-negative infections in critically ill patients: preliminary results of an ESGCIP survey

    Garyfallia Poulakou, Athens, Greece

    Poulakou, G.(1)*; Matthaiou, D.K.(1); Bassetti, M.(2); Erdem, H.(3); Dimopoulos, G.(1); Carlet, J.(4); Lipman, J.(5); Timsit, J.F.(6); Giamarellou, H.(1); Rello, J.(7);

    10 May 2014

    Session: Antibiotic choices: clinical studies

    Relevance:

     

    100%

     

    

    Event: ECCMID 2014
    Barcelona, Spain
    Poster presentation

    New Antibacterial Agents & Stewardship

13. A short overview of the pipeline

    Garyfallia Poulakou, Athens, Greece

    01 June 2013

    Relevance:

     

    100%

     

    

    Event: Hot Topics on Infections in the Critically Ill Patient
    Athens, Greece
    PGEC lecture

    Healthcare-associated & Nosocomial Infections, Infection Control

14. Handout

    Jason Roberts, Brisbane, Australia

    Garyfallia Poulakou, Athens, Greece

    Jordi Rello, Barcelona, Spain

    Alexis Tabah, Brisbane, Australia

    27 April 2013

    Session: EW02: Infections in the critically ill patients: the present and the future

    Relevance:

     

    100%

     

    

    Event: ECCMID 2013
    Berlin, Germany
    Workshop lecture

    Healthcare-associated & Nosocomial Infections, Infection Control

15. W10

    Salvage therapy in the critically ill patient: new frontiers

    Garyfallia Poulakou, Athens, Greece

    27 April 2013

    Session: Infections in the critically ill patients: the present and the future

    Relevance:

     

    100%

     

    

    Event: ECCMID 2013
    Berlin, Germany
    Workshop lecture

    Healthcare-associated & Nosocomial Infections, Infection Control

16. Handout

    Helen Giamarellou, Maroussi, Athens, Greece

    Garyfallia Poulakou, Athens, Greece

    Jordi Rello, Barcelona, Spain

    Antonio Anzueto, San Antonio, United States

    31 March 2012

    Session: EW06: Last frontier on infections in critically ill patients

    Relevance:

     

    100%

     

    

    Event: ECCMID 2012
    London, United Kingdom
    Workshop lecture

    Healthcare-associated & Nosocomial Infections, Infection Control

17. The HIV-positive patient with community acquired pneumonia

    Garyfallia Poulakou, Athens, Greece

    14 January 2012

    Relevance:

     

    100%

     

    

    Event: Innovation in Severe Acute Respiratory Infections (SARI)
    Sitges, Spain
    PGEC lecture

    Viral Infection & Disease

18. Interactive case 2

    Garyfallia Poulakou, Athens, Greece

    13 January 2012

    Relevance:

     

    100%

     

    

    Event: Innovation in Severe Acute Respiratory Infections (SARI)
    Sitges, Spain
    PGEC lecture

    Viral Infection & Disease

19. Tigecycline in the treatment of infections by carbapenemase-producing bacteria

    Garyfallia Poulakou, Athens, Greece

    02 December 2011

    Session: Therapeutic Challenges

    Relevance:

     

    100%

     

    

    Event: Carbapenemase-producing Gram-negative Microorganisms: Detection, Epidemiology and Therapeutic Challanges
    Athens, Greece
    PGEC lecture

    Bacterial Infection & Disease

20. Case 2.

    Garyfallia Poulakou, Athens, Greece

    21 May 2011

    Session: Interactive clinical case discussions

    Relevance:

     

    100%

     

    

    Event: Infections in Critically Ill Patients
    Athens, Greece
    PGEC lecture

    Bacterial Susceptibility & Resistance